Advertisement
Skip to Content

Franklin Biotechnology Discovery A FBDIX

Analyst rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 112.43  /  0.36 %
  • Total Assets 833.5 Mil
  • Adj. Expense Ratio
  • Expense Ratio 1.040%
  • Distribution Fee Level Low
  • Share Class Type Front Load
  • Category Health
  • Investment Style Mid Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.13%
  • Turnover 26%

Morningstar’s Analysis FBDIX

Will FBDIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

An expanding universe presents challenges.

Senior Analyst

Summary

|

Franklin Biotechnology Discovery is overseen by experienced managers, but limited resources and an undifferentiated process earn the fund a Morningstar Analyst Rating of Neutral.

Unlock our full analysis with Morningstar Investor